Latest Balance Sheet News

Austral Resources Australia Ltd has launched a $40 million placement at 5 cents per share to fund the acquisition and recommissioning of the Rocklands copper project in Queensland. The offer includes share and option issues tied to debt conversions and is conditional on shareholder approval and ASX reinstatement.

Austral Resources Australia Ltd is undertaking a $40 million capital raise to restructure its balance sheet, settle key debts, and accelerate its consolidation strategy in Queensland’s copper-rich Mount Isa and Cloncurry region.

Core Lithium has launched a $10 million Share Purchase Plan offering eligible shareholders the chance to buy new shares at the same price as a recent institutional placement, aiming to bolster working capital and support key project developments.

Acrux Limited has received a $3.04 million R&D Tax Incentive rebate for FY25 and fully repaid its short-term funding facility, underscoring its commitment to Australian pharmaceutical innovation.

Iress Limited has appointed Andrew Russell as its new Group CEO, marking a strategic leadership shift following a major company transformation. Russell’s extensive fintech experience positions him to lead Iress into a product and client-focused future.

Cyprium Metals has completed the first tranche of a significant capital raise, securing approximately A$74 million to advance its copper development projects in Western Australia. The second tranche awaits shareholder approval, underscoring investor confidence in the company’s growth strategy.

Mandrake Resources has completed detailed mapping of the Precambrian basement at its Utah Lithium Project, revealing structural features that could concentrate lithium-rich brines. This milestone advances a brine flow modelling study aimed at pinpointing high-grade lithium zones within a 3.3Mt inferred resource.

Amaero Ltd has updated its FY2026 financial guidance, forecasting revenue between A$30 million and A$35 million; a staggering 800%-900% increase year-over-year; and announced a A$50 million capital raise to expand production capacity and reduce costs.

Tasmea Limited has firmly denied recent media speculation about potential block trades by its executive directors, reaffirming their strong shareholding and commitment to growth. The company is focused on organic expansion and acquisitions to secure ASX 300 inclusion next year without raising new capital.

AssetOwl Limited proposes converting $163,411 of debt into 100 million new shares, continuing its strategic debt reduction efforts ahead of shareholder approval.

Cambium Bio has struck a licensing deal with Keke Medtech to commercialise its fibrin biologic in dental applications, unlocking new markets and non-dilutive funding.

CZR Resources has satisfied all conditions precedent for the sale of its Robe Mesa Iron Ore Project, with completion set for 9 September 2025. This milestone marks a significant cash inflow for the company.